Time-related decrease in sensitivity to ergonovine in patients with variant angina

Mario Previtali, Claudio Panciroli, Roberto De Ponti, Marcello Chimienti, Carlo Montemartini, Jorge A. Salerno

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Eighteen patients with variant angina, a positive ergonovine test, and a favorable response to calcium antagonists were studied by serial ergonovine tests and Holter monitoring to assess the long-term changes in response to ergonovine and the relationship with the spontaneous activity of the disease. The number of patients with a positive test decreased from 18 of 18 in the acute phase to 12 of 18 (66%) at 3 months, 10 of 17 (59%) at 6 months, and five of 17 (29%) at 12 months. The mean dose level of ergonovine associated with a positive response and the percentage of positive tests with ST segment depression increased progresively during follow-up. The results of the ergonovine test were well correlated with the spontaneous activity of the disease in 94%, 83%, 76%, and 71% of the patients at initial observation and at 3, 6 and 12 months, respectively. Thus in patients with variant angina and a favorable response to calcium antagonists, a time-related decrease in sensitivity to ergonovine develops during follow-up. In most patients the response to ergonovine is well correlated with the spontaneous activity of the disease; thus the ergonovine test may be a useful tool in the assessment of the natural evolution of vasospastic angina.

Original languageEnglish
Pages (from-to)92-99
Number of pages8
JournalAmerican Heart Journal
Volume117
Issue number1
DOIs
Publication statusPublished - 1989

Fingerprint

Ergonovine
Calcium
Ambulatory Electrocardiography
Observation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Previtali, M., Panciroli, C., Ponti, R. D., Chimienti, M., Montemartini, C., & Salerno, J. A. (1989). Time-related decrease in sensitivity to ergonovine in patients with variant angina. American Heart Journal, 117(1), 92-99. https://doi.org/10.1016/0002-8703(89)90661-3

Time-related decrease in sensitivity to ergonovine in patients with variant angina. / Previtali, Mario; Panciroli, Claudio; Ponti, Roberto De; Chimienti, Marcello; Montemartini, Carlo; Salerno, Jorge A.

In: American Heart Journal, Vol. 117, No. 1, 1989, p. 92-99.

Research output: Contribution to journalArticle

Previtali, M, Panciroli, C, Ponti, RD, Chimienti, M, Montemartini, C & Salerno, JA 1989, 'Time-related decrease in sensitivity to ergonovine in patients with variant angina', American Heart Journal, vol. 117, no. 1, pp. 92-99. https://doi.org/10.1016/0002-8703(89)90661-3
Previtali, Mario ; Panciroli, Claudio ; Ponti, Roberto De ; Chimienti, Marcello ; Montemartini, Carlo ; Salerno, Jorge A. / Time-related decrease in sensitivity to ergonovine in patients with variant angina. In: American Heart Journal. 1989 ; Vol. 117, No. 1. pp. 92-99.
@article{2910e413c46841c09ad6c2e8ca7c59da,
title = "Time-related decrease in sensitivity to ergonovine in patients with variant angina",
abstract = "Eighteen patients with variant angina, a positive ergonovine test, and a favorable response to calcium antagonists were studied by serial ergonovine tests and Holter monitoring to assess the long-term changes in response to ergonovine and the relationship with the spontaneous activity of the disease. The number of patients with a positive test decreased from 18 of 18 in the acute phase to 12 of 18 (66{\%}) at 3 months, 10 of 17 (59{\%}) at 6 months, and five of 17 (29{\%}) at 12 months. The mean dose level of ergonovine associated with a positive response and the percentage of positive tests with ST segment depression increased progresively during follow-up. The results of the ergonovine test were well correlated with the spontaneous activity of the disease in 94{\%}, 83{\%}, 76{\%}, and 71{\%} of the patients at initial observation and at 3, 6 and 12 months, respectively. Thus in patients with variant angina and a favorable response to calcium antagonists, a time-related decrease in sensitivity to ergonovine develops during follow-up. In most patients the response to ergonovine is well correlated with the spontaneous activity of the disease; thus the ergonovine test may be a useful tool in the assessment of the natural evolution of vasospastic angina.",
author = "Mario Previtali and Claudio Panciroli and Ponti, {Roberto De} and Marcello Chimienti and Carlo Montemartini and Salerno, {Jorge A.}",
year = "1989",
doi = "10.1016/0002-8703(89)90661-3",
language = "English",
volume = "117",
pages = "92--99",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Time-related decrease in sensitivity to ergonovine in patients with variant angina

AU - Previtali, Mario

AU - Panciroli, Claudio

AU - Ponti, Roberto De

AU - Chimienti, Marcello

AU - Montemartini, Carlo

AU - Salerno, Jorge A.

PY - 1989

Y1 - 1989

N2 - Eighteen patients with variant angina, a positive ergonovine test, and a favorable response to calcium antagonists were studied by serial ergonovine tests and Holter monitoring to assess the long-term changes in response to ergonovine and the relationship with the spontaneous activity of the disease. The number of patients with a positive test decreased from 18 of 18 in the acute phase to 12 of 18 (66%) at 3 months, 10 of 17 (59%) at 6 months, and five of 17 (29%) at 12 months. The mean dose level of ergonovine associated with a positive response and the percentage of positive tests with ST segment depression increased progresively during follow-up. The results of the ergonovine test were well correlated with the spontaneous activity of the disease in 94%, 83%, 76%, and 71% of the patients at initial observation and at 3, 6 and 12 months, respectively. Thus in patients with variant angina and a favorable response to calcium antagonists, a time-related decrease in sensitivity to ergonovine develops during follow-up. In most patients the response to ergonovine is well correlated with the spontaneous activity of the disease; thus the ergonovine test may be a useful tool in the assessment of the natural evolution of vasospastic angina.

AB - Eighteen patients with variant angina, a positive ergonovine test, and a favorable response to calcium antagonists were studied by serial ergonovine tests and Holter monitoring to assess the long-term changes in response to ergonovine and the relationship with the spontaneous activity of the disease. The number of patients with a positive test decreased from 18 of 18 in the acute phase to 12 of 18 (66%) at 3 months, 10 of 17 (59%) at 6 months, and five of 17 (29%) at 12 months. The mean dose level of ergonovine associated with a positive response and the percentage of positive tests with ST segment depression increased progresively during follow-up. The results of the ergonovine test were well correlated with the spontaneous activity of the disease in 94%, 83%, 76%, and 71% of the patients at initial observation and at 3, 6 and 12 months, respectively. Thus in patients with variant angina and a favorable response to calcium antagonists, a time-related decrease in sensitivity to ergonovine develops during follow-up. In most patients the response to ergonovine is well correlated with the spontaneous activity of the disease; thus the ergonovine test may be a useful tool in the assessment of the natural evolution of vasospastic angina.

UR - http://www.scopus.com/inward/record.url?scp=0024501692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024501692&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(89)90661-3

DO - 10.1016/0002-8703(89)90661-3

M3 - Article

VL - 117

SP - 92

EP - 99

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1

ER -